Endoplasmic reticulum (ER) News and Research

RSS

Patients focus on high cost of ER care

The Philadelphia Inquirer reports on the high cost of emergency room visits and "a changing health-care world, in which patients must think more like accountants and also like doctors. Make the right decision, and you could save thousands of dollars. Choose wrong, particularly about the ER, and you could lose your life. 'It is a dilemma for an average person: What is a real emergency?' said Martin Rosen, executive vice president of Health Advocate Inc. in Plymouth Meeting, which helps patients with medical or billing issues.

15 Apr 2010

Connectyx Technologies Holdings Group, Consult A Doctor sign joint venture

Connectyx Technologies Holdings Group Inc. is pleased to announce that the Company has signed a joint marketing agreement with Consult A Doctor to provide MedFlash® Personal Health Manager (PHM) to the more than 36 million Americans who are currently being treated via Telemedicine.

9 Apr 2010

Parents lack understanding of causes, signs and symptoms of dehydration in children

Dehydration is a condition that can have a significant impact on children and, if left untreated, may lead to serious complications and hospitalization. A national survey of more than 800 parents with children between the ages of one month and 10 years found that three out of five parents reported needing to know more information about dehydration, such as when to see a physician, warning signs, and treatment, if their child became sick - pointing to a greater need for awareness and education around the condition and its treatment.

From Baxter International Inc. 8 Apr 2010

Payers, benefits administrators look for ways to reduce costs of managing benefits programs

Sending communications on healthcare benefits through the mail is an important channel in engaging members as they make benefits decisions and as program managers seek to influence member behavior, according to a study on Healthcare Benefit Communications Preferences by Pitney Bowes Management Services, Inc., a wholly owned subsidiary of Pitney Bowes Inc.

7 Apr 2010

MHS to deploy NextGen EHR and NextGen HIE management solutions

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, today announced an agreement with Mercy Health System to deploy NextGen® EHR and NextGensm Health Information Exchange.

6 Apr 2010

Hospital ER wait time via text messaging

The first wave of Spring Breakers has hit the sugar white sands of Panama City Beach, Florida. While most don't plan on a trip to the emergency department while they're on vacation, some end up there. And when they need emergency care, Gulf Coast Medical Center has made it easy for vacationers to find out how long they may have to wait for treatment before they leave for the hospital.

5 Apr 2010

Therapeutic hypothermia helps save marathon cardiac arrest victim

Jay Yim, 21, had worked on improving his fitness since age 15. In preparation for this year's Los Angeles Marathon on March 21, the University of Southern California pre-med student had been training with a marathon club and regularly did 10-mile runs on his own.

3 Apr 2010

Mount Sinai Medical Center's overall revenue growth for 2009 increased by 5%

Demonstrating the fortitude to address a challenging healthcare environment, president and C.E.O. Steven D. Sonenreich has led Mount Sinai Medical Center to financial stability and successfully reinforced its image as a healthcare leader. The most recent audit posted on March 26 reports nearly $14 million in profit for 2009.

1 Apr 2010

Pramipexole ER uptake to be inhibited by availability of generic version

HealthLeaders-InterStudy and Fingertip Formulary find that the uptake of Boehringer Ingelheim's pramipexole ER, the once-daily formulation of its market leading dopamine agonist Mirapex that was approved earlier this month, will be inhibited by competition from generic pramipexole which became available earlier this year.

1 Apr 2010

Hospital outpatient ER visits by Medicaid recipients increased more than 6%

SDI, a leading healthcare market insight and analytics firm, today reported that the number of Medicaid-subsidized inpatient hospital stays originating in the emergency room increased more than 6% in 2009 compared to 2008. The growth rate of all inpatient hospital stays that began in the hospital outpatient ER was less at just over 1%.

31 Mar 2010

Researcher explores the use of Chinese wolfberries to improve vision deficiencies

A Kansas State University researcher is exploring the use of Chinese wolfberries to improve vision deficiencies that are common for type-2 diabetics.

31 Mar 2010

ER stress response is major driver of insulin resistance, say researchers

Biologists have long known that an enzyme called the PI 3-kinase is a crucial actor in the main molecular pathway for insulin signaling in cells. Researchers at Joslin Diabetes Center now have uncovered startling evidence that one of the proteins in this enzyme also drives a pathway with an opposite result-triggering a stress response that leads to insulin resistance.

29 Mar 2010

New approach may circumvent lost response in insulin due to obesity

Researchers at Children's Hospital Boston have identified a new strategy for treating type 2 diabetes, identifying a cellular pathway that fails when people become obese. By activating this pathway artificially, they were able to normalize blood glucose levels in severely obese and diabetic mice. Their findings will be published online by Nature Medicine on March 28.

29 Mar 2010

Health Canada accepts Cipher Pharmaceuticals' NDS for CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that its New Drug Submission (NDS) to Health Canada for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for review. The Company expects the review to be completed by early 2011.

26 Mar 2010

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.

26 Mar 2010

Predominantly white, insured and sick patients frequently use ER

Frequent users of the emergency department are predominantly white, insured and at greater risk for hospitalization due to serious illness, despite public perceptions of them as abusers of the healthcare system with minor complaints and no health insurance. This is the consensus of a systematic review of two dozen published studies of so-called "frequent flyers" ("Frequent Users of Emergency Departments: The Myths, the Data, and the Policy Implications").

19 Mar 2010

Competitive bidding program for durable medical equipment: Myths and realities

Medicare has been touting the merits of the "competitive" bidding program for durable, or home medical equipment and services (HME) to convince Congress that the program is good for seniors. Unfortunately, proponents have conveyed misleading information and cherry-picked facts that exaggerate the benefits and ignore the severe shortcomings of the program.

18 Mar 2010

Virtuoso Digital Pathology Software: BioImagene adds Companion Algorithms for colon cancer

BioImagene, Inc., the leading provider of end-to-end digital pathology solutions, today announced the availability of Companion Algorithms™ for colon cancer in their Virtuoso™ Digital Pathology Software. BioImagene’s Companion Algorithms are unique in the digital pathology industry as they are specific to a biomarker and a tissue type. Therefore, pathologists are not faced with the challenges of customizing generic algorithms in order to make them work.

18 Mar 2010

Agendia to participate in groundbreaking clinical trial for breast cancer

Agendia, a world leader in molecular cancer diagnostics, announced today it will participate in the highly anticipated I-SPY 2 TRIAL for breast cancer, set to launch at the first of nearly twenty research sites.

18 Mar 2010

MedSolutions launches oncology management program for cancer patients

MedSolutions (www.medsolutions.com), a leading provider of medical cost management services, today announced the launch of its oncology management program, which uses evidence-based guidelines to ensure appropriate use of diagnostic imaging, radiation therapy and drugs for cancer patients.

17 Mar 2010